Open AccessAbstract CT185: A phase II neoadjuvant trial of Interferon-gamma plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer
Author(s) -
Hyo S. Han,
Dawn Goodridge,
Avan Armaghani,
Raphael Raniere de Oliveira Costa,
Aixa Müller,
Loretta Loftus,
Hatem Soliman,
Brooke L. Fridley,
Laila Khazai,
Aiana Cerezo,
Jesse Hevia,
Marilin Rosa,
Hung T. Khong,
Brian J. Czerniecki
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct185
Subject(s) - trastuzumab , pertuzumab , medicine , taxane , breast cancer , oncology , interim analysis , paclitaxel , phases of clinical research , chemotherapy , cancer , clinical trial